Skip to main content
Intended for healthcare professionals
Restricted access
Research article
First published May 1976

Effects of Immunostimulants on Resistance of Newborn Mice to Herpes Simplex Type 2 Infection

Summary

Since age-dependent diminished macrophage function has been related to the increased susceptibility of newborn mice to herpes simplex virus (HSV) infection, the effect of several agents which might activate macrophages or other cells involved in immunity was investigated. BCG, typhoid vaccine, brucella vaccine, levamisole, or staphage lysate were administered to newborn mice prior to challenge with HSV-2. Of these agents, only BCG, administered ip or id 6 days prior to challenge, was found to increase the survival rate of newborn mice. The possible use of BCG, alone or in combination with other modalities, for the prevention or treatment of neonatal HSV infections is discussed.

Get full access to this article

View all access and purchase options for this article.

Cite article

Cite article

Cite article

OR

Download to reference manager

If you have citation software installed, you can download article citation data to the citation manager of your choice

Share options

Share

Share this article

Share with email
EMAIL ARTICLE LINK
Share on social media

Share access to this article

Sharing links are not relevant where the article is open access and not available if you do not have a subscription.

For more information view the Sage Journals article sharing page.

Information, rights and permissions

Information

Published In

Article first published: May 1976
Issue published: May 1976

Authors

Affiliations

Aarolyn M. Visintine
Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia 30303

Metrics and citations

Metrics

Journals metrics

This article was published in Experimental Biology and Medicine.

VIEW ALL JOURNAL METRICS

Article usage*

Total views and downloads: 28

*Article usage tracking started in December 2016


Altmetric

See the impact this article is making through the number of times it’s been read, and the Altmetric Score.
Learn more about the Altmetric Scores



Articles citing this one

Receive email alerts when this article is cited

Web of Science: 0

Crossref: 63

  1. Mycobacterium tuberculosis and SARS-CoV-2 co-infections: The knowns an...
    Go to citation Crossref Google Scholar
  2. Epigenetic modifications and regulation in infection
    Go to citation Crossref Google Scholar
  3. The mechanisms and cross-protection of trained innate immunity
    Go to citation Crossref Google Scholar
  4. Heat inactivated mycobacteria, alpha‐Gal and zebrafish: Insights gaine...
    Go to citation Crossref Google Scholar
  5. Shifting the Immune Memory Paradigm: Trained Immunity in Viral Infecti...
    Go to citation Crossref Google Scholar
  6. BCG Vaccination: A potential tool against COVID-19 and COVID-19-like B...
    Go to citation Crossref Google Scholar
  7. Fiction and Facts about BCG Imparting Trained Immunity against COVID-1...
    Go to citation Crossref Google Scholar
  8. Trained immunity-related vaccines: innate immune memory and heterologo...
    Go to citation Crossref Google Scholar
  9. Tuberculosis vaccine BCG: the magical effect of the old vaccine in the...
    Go to citation Crossref Google Scholar
  10. Seroprevalence of severe acute respiratory syndrome coronavirus 2 immu...
    Go to citation Crossref Google Scholar
  11. The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guér...
    Go to citation Crossref Google Scholar
  12. New insights into genetic characteristics between multiple myeloma and...
    Go to citation Crossref Google Scholar
  13. Single-cell transcriptomic profiles reveal changes associated with BCG...
    Go to citation Crossref Google Scholar
  14. The Diverse Applications of Recombinant BCG-Based Vaccines to Target I...
    Go to citation Crossref Google Scholar
  15. Cheap and Commonplace: Making the Case for BCG and γδ T Cells in COVID...
    Go to citation Crossref Google Scholar
  16. What Could Explain the Lower COVID-19 Burden in Africa despite Conside...
    Go to citation Crossref Google Scholar
  17. The Innate Immune Response to Mycobacterium tuberculosis...
    Go to citation Crossref Google Scholar
  18. COVID 19 Pandemic; A Review on Understanding the Mode of Transmission ...
    Go to citation Crossref Google Scholar
  19. Pharmacotherapeutics of SARS-CoV-2 Infections
    Go to citation Crossref Google Scholar
  20. BCG vaccination induced protection from COVID-19
    Go to citation Crossref Google Scholar
  21. BCG immunomodulation: From the ‘hygiene hypothesis’ to COVID-19
    Go to citation Crossref Google Scholar
  22. BCG Vaccine-Induced Trained Immunity and COVID-19: Protective or Bysta...
    Go to citation Crossref Google Scholar
  23. Does bacillus Calmette‐Guérin vaccine prev...
    Go to citation Crossref Google Scholar
  24. Coronavirus vaccine development: from SARS and MERS to COVID-19
    Go to citation Crossref Google Scholar
  25. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Popu...
    Go to citation Crossref Google Scholar
  26. Evidence for Anti-Viral Effects of Complete Freund’s Adjuvant in the M...
    Go to citation Crossref Google Scholar
  27. A cytokine super cyclone in COVID-19 patients with risk factors: the t...
    Go to citation Crossref Google Scholar
  28. Safety and COVID-19 Symptoms in Individuals Recently Vaccinated with B...
    Go to citation Crossref Google Scholar
  29. BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine?
    Go to citation Crossref Google Scholar
  30. Prevention and treatment of COVID‐19 disease by controlled modulation ...
    Go to citation Crossref Google Scholar
  31. BCG-induced trained immunity: can it offer protection against COVID-19...
    Go to citation Crossref Google Scholar
  32. Trained Immunity: a Tool for Reducing Susceptibility to and the Severi...
    Go to citation Crossref Google Scholar
  33. CORONAVIRUS VACCINE DEVELOPMENT: FROM SARS AND MERS TO COVID-19 (RUSSI...
    Go to citation Crossref Google Scholar
  34. Non-specific effects of BCG vaccine on viral infections
    Go to citation Crossref Google Scholar
  35. Mucosal Immunity to Herpes Simplex Virus Type 2 Infection in the Mouse...
    Go to citation Crossref Google Scholar
  36. Protective immunity against HSV-2 in the mouse vagina
    Go to citation Crossref Google Scholar
  37. Herpes Simplex Vaccines
    Go to citation Crossref Google Scholar
  38. Natural Resistance to Herpes Simplex Virus Infections: The Macrophage-...
    Go to citation Crossref Google Scholar
  39. Protection of Mice against Herpes Simplex Virus Infection by a ...
    Go to citation Crossref Google Scholar
  40. Effect of thymopentin on the mortality and immune response after an ex...
    Go to citation Crossref Google Scholar
  41. The Role of Interferon in Immunity and Prophylaxis
    Go to citation Crossref Google Scholar
  42. Effects of Immunopotentiating and Immunomodulating Agents on Experimen...
    Go to citation Crossref Google Scholar
  43. Natural Resistance Mechanisms in Herpes Simplex Virus Infections
    Go to citation Crossref Google Scholar
  44. Protection of Mice against Infection with Mouse Hepatitis Virus Type 3...
    Go to citation Crossref Google Scholar
  45. Recovery from lethal herpes simplex virus type 1 infection is mediated...
    Go to citation Crossref Google Scholar
  46. Mode of Protection of Mice against Herpes Simplex Virus Type 2 Infecti...
    Go to citation Crossref Google Scholar
  47. Enhancement of Natural Resistance to Influenza Virus in Lipopolysaccha...
    Go to citation Crossref Google Scholar
  48. Immunology of Herpes Simplex Viruses
    Go to citation Crossref Google Scholar
  49. Immunotherapy and Immunoregulation
    Go to citation Crossref Google Scholar
  50. Protectivity of herpes simplex virus antigens: Studies in mice on the ...
    Go to citation Crossref Google Scholar
  51. Protection of mice against mouse hepatitis virus by Corynebacterium pa...
    Go to citation Crossref Google Scholar
  52. Systemic Application of Antivirals for Herpes Infections
    Go to citation Crossref Google Scholar
  53. Immunopotentiation in Experimental Viral Infections
    Go to citation Crossref Google Scholar
  54. Protection and therapy of mice with acute and chronic experimental vir...
    Go to citation Crossref Google Scholar
  55. Ontogeny of murine cellular cytotoxicity to herpes simplex virus-infec...
    Go to citation Crossref Google Scholar
  56. The effect of BCG-vaccination on vaccinia virus infections in mice
    Go to citation Crossref Google Scholar
  57. Therapeutic control of viral infections: Chemotherapy, interferon and ...
    Go to citation Crossref Google Scholar
  58. Role of macrophages in natural resistance to virus infections
    Go to citation Crossref Google Scholar
  59. Replication of herpes simplex virus type 1 in macrophages from resista...
    Go to citation Crossref Google Scholar
  60. Success of Antiviral Therapy Involves Cooperative Immune Responses
    Go to citation Crossref Google Scholar
  61. Human neonatal and maternal monocyte-macrophage and lymphocyte-mediate...
    Go to citation Crossref Google Scholar
  62. Immunological Studies of HSV-Infection of Resistant and Susceptible In...
    Go to citation Crossref Google Scholar
  63. Protection against herpes simplex virus infection in mice by Corynebac...
    Go to citation Crossref Google Scholar

Figures and tables

Figures & Media

Tables

View Options

Get access

Access options

If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:

SEBM members can access this journal content using society membership credentials.

SEBM members can access this journal content using society membership credentials.


Alternatively, view purchase options below:

Purchase 24 hour online access to view and download content.

Access journal content via a DeepDyve subscription or find out more about this option.

View options

PDF/ePub

View PDF/ePub